Telesis Bio, Inc. Common Stock (TBIO)

TBIO was delisted on the 27th of September, 2024.

• Market cap: $5.73M
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.

Employees: 110